Page 16 | Certara

Press Coverage

The Medicine Maker: The Biosimulation Generation

The article, The Biosimulation Generation, explores the transformative potential of biosimulation in pharmaceutical R&D as…

Danielle PillsburyJuly 1, 2025

Blog

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

June 30, 2025 Drug development is increasingly defined by its complexity. Teams must navigate rising…

CertaraJune 30, 2025

Blog

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

Maintain the credibility of your pharma market access digital tools through continuous updates based on…

CertaraJune 30, 2025

Blog

The Do’s and Don’ts of Define.xml

Discover the 6 dos and don’ts of creating compliant define.xml files for FDA submission with…

CertaraJune 27, 2025

Case Study

How Model-informed drug development rescue projects from a risky situation

Discover how Certara’s integrated approach to model-informed drug development helps clients navigate regulatory challenges, achieve…

CertaraJune 26, 2025

Press Coverage

Increasing Productivity In Pharma R&D Starts With Data

This article discusses the growing volume of raw data collected during clinical research, and how…

CertaraJune 25, 2025

Blog

FDA ESG NextGen for Regulatory Submissions

The FDA ESG NextGen for Regulatory Submissions has replaced the FDA’s WebTrader and simplifies pharmaceutical…

CertaraJune 25, 2025

Poster

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Learn how a QSP platform predicts ADA and PK effects in combo immunotherapies like nivolumab…

CertaraJune 23, 2025

Announcement

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Radnor, PA – June 20, 2025 - Certara, Inc. (Nasdaq: CERT), a global leader in…

Danielle PillsburyJune 20, 2025

Publication

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Due to the highly controlled settings of clinical trials, enrolled subjects may not be fully…

CertaraJune 19, 2025

The Medicine Maker: The Biosimulation Generation

5 Clinical Development Challenges Model-Based Meta-Analysis (MBMA) Helps Address

Maintain & Adapt Pharma Market Access Digital Tools Using Feedback

The Do’s and Don’ts of Define.xml

How Model-informed drug development rescue projects from a risky situation

Increasing Productivity In Pharma R&D Starts With Data

FDA ESG NextGen for Regulatory Submissions

Applications of an Immunogenicity QSP Platform: Predictive Modelling for ADA and PK Impact for Biotherapeutic Combinations

Certara Enhances Integral Data Repository with Powerful REST API Capabilities in Version 25.4.1

Critical Roles for Modeling and Simulation and Real-World Evidence to Inform Challenges in Clinical Trial Diversity Planning

Newsletter sign up

Quick links

Solutions

Contact